Effect of Direct-Acting Antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients
The achievement of high rates of sustained virological response (SVR) with direct-acting antivirals (DAAs) in hepatitis C virus (HCV) infected patients will reduce decompensating terminal events.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Alessandro Cucchetti, Gennaro D ’Amico, Franco Trevisani, Maria Cristina Morelli, Alessandro Vitale, Antonio Daniele Pinna, Matteo Cescon, from the Special Interest Group onHepatocellular carcinoma and new anti HCV therapie of the Italian Association fo Tags: Liver, Pancreas and Biliary Tract Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Italy Health | Liver | Liver Cancer | Liver Disease | Pancreas | Pancreatic Cancer | Urology & Nephrology | Virology